1. Malmberg K, Ryde Â n L, Efendic S et al. on behalf of the DI-GAMI Study Group (1995) Randomized trial of insulinglucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol 26: 57±65 2. Malmberg K, Ryde Â n L, Hamsten A, Herlitz J, Waldenstro È m A, Wedel H on behalf of the DIGAMI STUDY GROUP (1996) Effects of insulin treatment on cause-specific oneyear mortality and morbidity in diabetic patients with acute myocardial infarction. Eur Heart J 17: 1337±1344 3. Malmberg K for the DIGAMI Study Group (1997) [2] indicates that IDDM patients with islet cell antibodies (ICA) and the np 3243 mutation tend to have IDDM-related human leukocyte antigen (HLA) genotype. They hypothesized that in the presence of IDDM-associated HLA types, the mtDNA mutation at np 3243 increases the risk for IDDM with islet autoimmunity. The np 3243 mutation is present in about 1 % of Japanese non-insulin-dependent diabetic (NIDDM) patients [4] but is scarcely present in Japanese and Caucasian patients with autoimmune or juvenile-onset IDDM [5±7]. By analysing 1238 subjects, it has been reported that the positivities of protein tyrosine phosphatase-like IA-2 (ICA512/IA-2) autoantibodies and glutamic acid decarboxylase (GAD) autoantibodies correlate well with ICA positivity [8] . If the np 3243 mutation is causatively involved in autoimmune beta-cell destruction, GAD or IA-2 autoantibodies are also likely to be highly prevalent along with ICA as observed in populations with IDDM [8± 10]. However, the prevalence of associated GAD antibodies in diabetic patients with the np 3243 mutation remained as low as 6 % (2/31) in the study by Kobayashi et al. [2] , in contrast to the high prevalence of ICA (42 % [13/31] ). A recent observation [3] indicates that the np 3243 mutation is not associated with IA-2, which is the major part of antigens for ICAs [10, 11] , or with GAD antibodies. An association of ICA but not IA-2 or GAD antibodies in patients with the np 3243 mutation suggests a doubtful involvement of this mutation in the pathogenesis of most autoimmune IDDM, although the mutation may result in low ICA antibody titres in some patients. These observations are consistent with previous reports by ourselves and others that the np 3243 mutation is not found in IDDM populations [5±7] or with autoimmune thyroid diseases [5, 12] , that are present with increased frequency in IDDM patients.
To investigate a possible involvement of the np 3243 mutation in the pathogenesis of autoimmune IDDM, we reviewed previous publications on the screening of IDDM and autoimmune thyroid diseases (Table 1) . Of nine studies in only one other study apart from that by Kobayashi et al. were IDDM patients reported to have this mutation. In that study, however, the patients carrying the np 3243 mutation do not seem to be typical autoimmune IDDM patients, but insulin-requiring NIDDM. The prevalence of the np 3243 mutation was markedly increased (11.1 %) in the study by Kobayashi et al. [1] compared with the other studies [1, 4±7, 12±14] (0.49 %), studies other than theirs [4±7, 12±14] (0.25 %) or the studies on typical IDDM [4±7, 12, 13] (0 %). The association of betacell antibodies (ICA/IA-2, GAD) was observed only in their study (3/3, 100 %), in contrast to the absent association in four other studies [3, 7, 13 , 15] (0/32, 0 % for ICA/IA-2, 0/29, 0 % for GAD). Among typical IDDM and autoimmune thyroid diseases, none of 1151 patients carried this mutation (Table 1). It is difficult to exclude the possibility that the association of ICA with the np 3243 mutation, observed by Kobayashi et al., is spurious, as indicated by Taniyama et al. [3] . It is also possible that the association does exist in some patients with atypical insulin-requiring diabetes. However, the association observed by Kobayashi et al. does not necessarily indicate that the np 3243 mutation in the presence of IDDM-prone HLA type is causatively associated with autoimmune IDDM.
It only indicates that the diabetic patients with IDDM-prone HLA and the np 3243 mutation tended to have a low titre of ICA with a non-restricted pattern of staining on an indirect immunofluorescence test. The ICA positivity observed in the diabetic patients with the np 3243 mutation, may not be a principal cause of beta-cell destruction leading to IDDM. It may be a result of beta-cell destruction or altered antigen presentation associated with the np 3243 mutation. In conclusion, even if IDDM-prone HLA was found with increased frequency in patients with the np 3243 mutation of the mtDNA, it seems to be premature to conclude that the np 3243 mutation increases the risk of development of autoimmune IDDM. And it seems unlikely that the A-to-G mutation at np 3243 of the mtDNA is a major cause of autoimmune IDDM. Response from the authors Dear Sir, We read with interest the comment by Drs. Odawara and Yamashita claiming a minor contribution of the mitochondrial DNA mutation at 3243 bp (A to G) (mtDNA 3243 mutation) to the aetiology of autoimmune insulin-dependent diabetes mellitus (IDDM). We would like to emphasize that a high proportion of diabetic patients with the mtDNA 3243 mutation have cytoplasmic islet cell antibodies (ICA) and an IDDM-related HLA-DQ allele [1] . Our diabetic patients with mtDNA 3243 mutation included subjects with various clinical phenotypes of diabetes ranging from non-insulin-dependent diabetes (NIDDM) to IDDM [1] . The prevalence of mtDNA 3243 mutation is not high in IDDM patients, ranging from 0 to 11 % [2±4]. Thus, one cannot simply extrapolate from our results to a general conclusion that the mtDNA 3243 mutation forms a background for beta-cell destruction in a majority of IDDM patients. However, fasting serum Cpeptide levels were less than 0.17 nmol/l in 3 of 16 insulintreated diabetic patients in our previous report [1] , indicating that some of them actually had IDDM. A closer relationship between the mtDNA 3243 mutation and ICA was confirmed in Japanese and Caucasian populations [5, 6] . Oexle et al. [6] reported the presence of ICA in an extremely insulin-deficient diabetic mother (10 JDF units), and her son had impaired glucose tolerance (80 JDF units). They had at least one HLA-DQ allele associated with IDDM. Apparently, it is still premature to conclude that the presence of pancreatic autoantibodies in diabetic patients with the mtDNA 3243 mutation is a secondary consequence rather than a cause of betacell destruction. B lymphocyte mediated factor is essential in the development of autoimmune NOD mice [7] . It is generally assumed that IDDM is a heterogenous disease in which multiple loci and other factors influence the initiation and progression of beta-cell failure through immunological, viral and/or chemical mechanisms in an additive manner [8, 9] . In this context, mtDNA 3243 mutation constitutes one distinct genetic background for IDDM, even if a minor proportion of IDDM patients have this mutation. The relationships among the mtDNA 3243 mutation, pancreatic autoimmunity and beta-cell destruction may be clarified by analysing the pancreas in diabetic patients with the mutation.
We examined histological changes in the autopsied pancreases of 16 IDDM patients and 18 NIDDM patients [10] . One of 16 (6 %) IDDM pancreases had a high proportion of islet cells with mtDNA 3243 mutation, as well as some exocrine cells. We found beta-cells to be reduced along with decreased mitochondrial DNA-encoded enzyme related oxidative phosphorylation (OX-PHOS): cytochrome c oxidase (COX), as well as enhanced nuclear-encoded enzyme related OXPHOS: succinate dehydrogenase (SDH) in the affected pancreas. Hyperexpressed SDH (complex II) activity in the islet cells may accelerate damage to beta-cells through increased toxic hydroxyl radicals generated from the accelerated electron transport system via the enhanced complex II pathway, which generates four times more mitochondrial superoxide than electrons channelled via the complex I pathway [11] . DNA damage in beta cells due to toxic hydroxyl radicals is assumed to be a possible cause of IDDM [12] . CD8 + lymphocyte infiltration around the islets as well as pancreatic exocrine cells was also observed in the pancreas with the mutation.
In conclusion, pathological features in the pancreas of diabetic patients with the mitochondrial DNA mutation as well as humoral markers represented by ICA may provide new insights into the mechanisms of beta-cell destruction in at least one distinct clinical phenotype of IDDM.
Yours sincerely, T. Kobayashi, K. Nakanishi, T. Murase
